Chinese Clinical Oncology

• 综述与讲座 • Previous Articles     Next Articles

Progress on the prognostic values of serum C-reactive protein levels in patients with pancreatic cancer

YANG Jiacheng,CAI Xun,WANG Liwei.

  

  1. Department of Oncology, Shanghai First People’s Hospital, Shanghai Jiaotong University, Shanghai 200080, China
  • Received:2013-09-25 Revised:2013-11-05 Online:2014-07-30 Published:2014-07-30

Abstract: C-reactive protein(CRP) is a nonspecific but sensitive marker suggesting inflammation. It has been most widely used for clinical diagnosis and prognosis of cardiovascular diseases. In the last decade, the prediction of CRP in cancer has caused more and more attention from many scholars. A lot of research have demonstrated that elevated CRP level is a determinant predictor of lower survival rates in patients with several cancers such as gastrointestinal cancer and gynecologic tumor. In this review, we briefly summarize the prognostic values of preoperative and postoperative serum CRP levels in resectable pancreatic cancer, and of the pretherapeutic CRP levels in advanced pancreatic carcinoma, respectively. Although the results are still controversial, an elevated CRP, measured either postoperative or pretherapeutic, has been shown to predict poor survival in some clinical researches.

No related articles found!
Viewed
Full text
333
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 333

  From Others local
  Times 38 295
  Rate 11% 89%

Abstract
102
Just accepted Online first Issue
0 0 101
  From Others
  Times 102
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!